

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.98364737 |
| 2 | central nervous system myelination (GO:0022010) | 9.98364737 |
| 3 | fatty acid elongation (GO:0030497) | 5.83873890 |
| 4 | myelin maintenance (GO:0043217) | 5.44111731 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.43257811 |
| 6 | ensheathment of neurons (GO:0007272) | 5.40088780 |
| 7 | axon ensheathment (GO:0008366) | 5.40088780 |
| 8 | myelination (GO:0042552) | 5.32455184 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 5.24591623 |
| 10 | response to peptidoglycan (GO:0032494) | 5.22979065 |
| 11 | response to methylmercury (GO:0051597) | 5.12009658 |
| 12 | L-amino acid import (GO:0043092) | 5.02846746 |
| 13 | glycosphingolipid catabolic process (GO:0046479) | 4.88310209 |
| 14 | response to lipoprotein particle (GO:0055094) | 4.57741390 |
| 15 | amyloid precursor protein metabolic process (GO:0042982) | 4.45760555 |
| 16 | glycolipid catabolic process (GO:0019377) | 4.37422585 |
| 17 | oligosaccharide catabolic process (GO:0009313) | 4.33668449 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.29574636 |
| 19 | import into cell (GO:0098657) | 4.23134165 |
| 20 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.22289408 |
| 21 | regulation of mononuclear cell migration (GO:0071675) | 4.12819784 |
| 22 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.10546037 |
| 23 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.08768863 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.07420055 |
| 25 | negative regulation of neurotransmitter transport (GO:0051589) | 4.04693014 |
| 26 | T-helper 1 type immune response (GO:0042088) | 4.00483381 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00331254 |
| 28 | amyloid precursor protein catabolic process (GO:0042987) | 3.95438161 |
| 29 | glycosylceramide metabolic process (GO:0006677) | 3.94984000 |
| 30 | negative regulation of protein localization to cell surface (GO:2000009) | 3.87299723 |
| 31 | glycerophospholipid catabolic process (GO:0046475) | 3.85372922 |
| 32 | regulation of collateral sprouting (GO:0048670) | 3.84146071 |
| 33 | ceramide catabolic process (GO:0046514) | 3.83937755 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.82797291 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.82018099 |
| 36 | amino sugar catabolic process (GO:0046348) | 3.75380412 |
| 37 | positive regulation of mast cell degranulation (GO:0043306) | 3.74449131 |
| 38 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.74449131 |
| 39 | creatine metabolic process (GO:0006600) | 3.70450571 |
| 40 | amino acid import (GO:0043090) | 3.63952532 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.63499826 |
| 42 | positive regulation of leukocyte degranulation (GO:0043302) | 3.63210783 |
| 43 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.62968757 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59779067 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.59779067 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59779067 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59779067 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59779067 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.59779067 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.54472414 |
| 51 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.51227474 |
| 52 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.48937301 |
| 53 | oligodendrocyte differentiation (GO:0048709) | 3.48881758 |
| 54 | regulation of lipoprotein metabolic process (GO:0050746) | 3.45591666 |
| 55 | negative regulation of macroautophagy (GO:0016242) | 3.45117197 |
| 56 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.44255308 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.43984060 |
| 58 | cellular extravasation (GO:0045123) | 3.43811762 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.43738585 |
| 60 | regulation of cholesterol storage (GO:0010885) | 3.42343399 |
| 61 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.42225929 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 3.38734237 |
| 63 | N-acetylneuraminate metabolic process (GO:0006054) | 3.38464208 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.37813924 |
| 65 | cholesterol biosynthetic process (GO:0006695) | 3.37792316 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.37495609 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 3.35834279 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.32342502 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.31852161 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.30951262 |
| 71 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.30356977 |
| 72 | response to thyroid hormone (GO:0097066) | 3.30203515 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.28983008 |
| 74 | membrane lipid catabolic process (GO:0046466) | 3.27229080 |
| 75 | protein localization to endosome (GO:0036010) | 3.25871822 |
| 76 | microglial cell activation (GO:0001774) | 3.24696962 |
| 77 | detection of other organism (GO:0098543) | 3.23191223 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18389929 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 3.17483672 |
| 80 | adult walking behavior (GO:0007628) | 3.17451919 |
| 81 | myeloid dendritic cell activation (GO:0001773) | 3.17311685 |
| 82 | regulation of mast cell activation (GO:0033003) | 3.16497444 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.12524702 |
| 84 | negative regulation of cell killing (GO:0031342) | 3.11324891 |
| 85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11324891 |
| 86 | membrane raft organization (GO:0031579) | 3.11165686 |
| 87 | monocyte chemotaxis (GO:0002548) | 3.11099995 |
| 88 | macrophage differentiation (GO:0030225) | 3.10991155 |
| 89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09003283 |
| 90 | regulation of podosome assembly (GO:0071801) | 3.08588351 |
| 91 | sphingolipid catabolic process (GO:0030149) | 3.08395736 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.08286649 |
| 93 | germinal center formation (GO:0002467) | 3.07200004 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07106494 |
| 95 | regulation of macrophage chemotaxis (GO:0010758) | 3.06743196 |
| 96 | sterol biosynthetic process (GO:0016126) | 3.06357393 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.05972533 |
| 98 | detection of external biotic stimulus (GO:0098581) | 3.05927169 |
| 99 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.97837587 |
| 100 | B cell mediated immunity (GO:0019724) | 2.97707104 |
| 101 | positive regulation of type 2 immune response (GO:0002830) | 2.95122129 |
| 102 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.92945364 |
| 103 | dendritic cell differentiation (GO:0097028) | 2.92033410 |
| 104 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91692135 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.89979539 |
| 106 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.89429337 |
| 107 | regulation of monocyte chemotaxis (GO:0090025) | 2.89293363 |
| 108 | mannose metabolic process (GO:0006013) | 2.89180838 |
| 109 | membrane tubulation (GO:0097320) | 2.87862192 |
| 110 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.87391509 |
| 111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86040350 |
| 112 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85292389 |
| 113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85053551 |
| 114 | detection of bacterium (GO:0016045) | 2.84591958 |
| 115 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.83835958 |
| 116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83774186 |
| 117 | positive regulation of interferon-alpha production (GO:0032727) | 2.83186815 |
| 118 | nerve growth factor signaling pathway (GO:0038180) | 2.82179181 |
| 119 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82122166 |
| 120 | adhesion of symbiont to host (GO:0044406) | 2.81302411 |
| 121 | regulation of interleukin-12 production (GO:0032655) | 2.80230830 |
| 122 | regulation of hypersensitivity (GO:0002883) | 2.79986972 |
| 123 | pinocytosis (GO:0006907) | 2.79933361 |
| 124 | magnesium ion transport (GO:0015693) | 2.79101395 |
| 125 | neutrophil activation (GO:0042119) | 2.78892065 |
| 126 | response to protozoan (GO:0001562) | 2.78802007 |
| 127 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78327106 |
| 128 | isoprenoid biosynthetic process (GO:0008299) | 2.77720440 |
| 129 | cellular response to lipopolysaccharide (GO:0071222) | 2.76604583 |
| 130 | detection of biotic stimulus (GO:0009595) | 2.76148426 |
| 131 | regulation of T cell tolerance induction (GO:0002664) | 2.75824741 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 2.75286063 |
| 133 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.75097488 |
| 134 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.74371654 |
| 135 | respiratory burst (GO:0045730) | 2.73930735 |
| 136 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.72303341 |
| 137 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.71659613 |
| 138 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.71659613 |
| 139 | photoreceptor cell differentiation (GO:0046530) | 2.70489092 |
| 140 | eye photoreceptor cell differentiation (GO:0001754) | 2.70489092 |
| 141 | glycine transport (GO:0015816) | 2.69394860 |
| 142 | asymmetric protein localization (GO:0008105) | 2.69161314 |
| 143 | tissue regeneration (GO:0042246) | 2.68912017 |
| 144 | axon development (GO:0061564) | 2.64042698 |
| 145 | astrocyte development (GO:0014002) | 2.59617646 |
| 146 | protein palmitoylation (GO:0018345) | 2.57996053 |
| 147 | cortical actin cytoskeleton organization (GO:0030866) | 2.57511723 |
| 148 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.54876731 |
| 149 | regulation of T cell migration (GO:2000404) | 2.53591040 |
| 150 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.52767017 |
| 151 | GPI anchor biosynthetic process (GO:0006506) | 2.51865470 |
| 152 | response to redox state (GO:0051775) | 2.51592274 |
| 153 | neuron remodeling (GO:0016322) | 2.50321955 |
| 154 | neurotransmitter uptake (GO:0001504) | 2.45772640 |
| 155 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.44344856 |
| 156 | presynaptic membrane organization (GO:0097090) | 2.41137387 |
| 157 | virion attachment to host cell (GO:0019062) | 2.40856861 |
| 158 | adhesion of symbiont to host cell (GO:0044650) | 2.40856861 |
| 159 | adenosine receptor signaling pathway (GO:0001973) | 2.40076255 |
| 160 | GPI anchor metabolic process (GO:0006505) | 2.39302950 |
| 161 | cortical cytoskeleton organization (GO:0030865) | 2.39192574 |
| 162 | positive regulation of gliogenesis (GO:0014015) | 2.39105294 |
| 163 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.37640392 |
| 164 | response to nerve growth factor (GO:1990089) | 2.37558680 |
| 165 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.37558680 |
| 166 | very long-chain fatty acid metabolic process (GO:0000038) | 2.37502522 |
| 167 | substantia nigra development (GO:0021762) | 2.35972560 |
| 168 | apical protein localization (GO:0045176) | 2.35324796 |
| 169 | macrophage activation (GO:0042116) | 2.34967744 |
| 170 | positive regulation of chemokine secretion (GO:0090197) | 2.33447325 |
| 171 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.32167143 |
| 172 | negative regulation of acute inflammatory response (GO:0002674) | 2.31766004 |
| 173 | regulation of lymphocyte migration (GO:2000401) | 2.31305285 |
| 174 | neuronal action potential propagation (GO:0019227) | 2.30183244 |
| 175 | enteric nervous system development (GO:0048484) | 2.29955890 |
| 176 | intracellular pH reduction (GO:0051452) | 2.29670252 |
| 177 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.28899743 |
| 178 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.28628600 |
| 179 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.26633601 |
| 180 | Golgi to endosome transport (GO:0006895) | 2.26047699 |
| 181 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.23065406 |
| 182 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.22964625 |
| 183 | regulation of macroautophagy (GO:0016241) | 2.22849228 |
| 184 | granulocyte activation (GO:0036230) | 2.22118878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.56478027 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18306356 |
| 3 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.99735992 |
| 4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.79473265 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63782049 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48917821 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.48418158 |
| 8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42967634 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42149075 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.38175496 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35801439 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.35689765 |
| 13 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.32344516 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30865552 |
| 15 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.28857992 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.24747576 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20387524 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19245080 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17462804 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10472080 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09607263 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01211315 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89462411 |
| 24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.82878348 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78104251 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75400855 |
| 27 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.74116252 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73919992 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73498058 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72564712 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70591175 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69625421 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68672285 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64789438 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60370607 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59991084 |
| 37 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.57784349 |
| 38 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55912215 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55025600 |
| 40 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53115913 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51085219 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.50863666 |
| 43 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.50815095 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50015415 |
| 45 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49487779 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48911394 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48747199 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47101594 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44270186 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44036133 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.43781960 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40547794 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39911877 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39587982 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38796744 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37199953 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37039439 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35242626 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35242626 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35223923 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35154880 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33472158 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.33045229 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32590690 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30902617 |
| 66 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30419052 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.29798389 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29328179 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28559209 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28089606 |
| 71 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27635485 |
| 72 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27635485 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26588990 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26155970 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25975100 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.25927186 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25850830 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25506752 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25333503 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24313407 |
| 81 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24176567 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23225850 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23141363 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21953528 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19462651 |
| 86 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19425601 |
| 87 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18908975 |
| 88 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.17729259 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17607918 |
| 90 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.17523771 |
| 91 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17379089 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17235530 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17103249 |
| 94 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16619410 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16241673 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15798606 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15156643 |
| 98 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12415808 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12047449 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11897887 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10571057 |
| 102 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10051784 |
| 103 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08816398 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08019140 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07779683 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 1.07385666 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06791663 |
| 108 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06411532 |
| 109 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05409648 |
| 110 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04439694 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03342008 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02758861 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02721928 |
| 114 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02333660 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01298910 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 1.00984251 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00871246 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00793649 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00479347 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00412853 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00345301 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00148205 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99677794 |
| 124 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.96619751 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95332618 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95331712 |
| 127 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.95297190 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95243719 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95032949 |
| 130 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93908117 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93760355 |
| 132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93683899 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93636693 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93460284 |
| 135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93252869 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93252857 |
| 137 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92982050 |
| 138 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92736931 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91794536 |
| 140 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90111191 |
| 141 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89319243 |
| 142 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88963587 |
| 143 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87701822 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87022758 |
| 145 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86867865 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86828497 |
| 147 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86762884 |
| 148 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86598276 |
| 149 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86085184 |
| 150 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.85482947 |
| 151 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85478287 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84882753 |
| 153 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84771423 |
| 154 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84617537 |
| 155 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84478019 |
| 156 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84447743 |
| 157 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83923780 |
| 158 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82584294 |
| 159 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81803712 |
| 160 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81784868 |
| 161 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81728227 |
| 162 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81034668 |
| 163 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80670580 |
| 164 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80186452 |
| 165 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80095797 |
| 166 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80028393 |
| 167 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.79690376 |
| 168 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79291600 |
| 169 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.78831645 |
| 170 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.78831645 |
| 171 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78057180 |
| 172 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.77916087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.28658398 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.62467941 |
| 3 | MP0003690_abnormal_glial_cell | 4.21788410 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.57579994 |
| 5 | MP0009840_abnormal_foam_cell | 3.04960023 |
| 6 | MP0000604_amyloidosis | 2.95491457 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.91275471 |
| 8 | MP0006082_CNS_inflammation | 2.81630637 |
| 9 | MP0003329_amyloid_beta_deposits | 2.79602602 |
| 10 | MP0009785_altered_susceptibility_to | 2.69780129 |
| 11 | MP0003634_abnormal_glial_cell | 2.48320039 |
| 12 | MP0004270_analgesia | 2.43858062 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.34012313 |
| 14 | MP0008260_abnormal_autophagy | 2.26247987 |
| 15 | MP0003880_abnormal_central_pattern | 2.23496773 |
| 16 | MP0005171_absent_coat_pigmentation | 2.21743800 |
| 17 | MP0000685_abnormal_immune_system | 2.09152634 |
| 18 | MP0005451_abnormal_body_composition | 2.08688001 |
| 19 | MP0003303_peritoneal_inflammation | 2.04709759 |
| 20 | MP0009278_abnormal_bone_marrow | 1.96027958 |
| 21 | MP0001529_abnormal_vocalization | 1.87635243 |
| 22 | MP0002419_abnormal_innate_immunity | 1.86642767 |
| 23 | MP0003632_abnormal_nervous_system | 1.84142434 |
| 24 | MP0004885_abnormal_endolymph | 1.83896573 |
| 25 | MP0001905_abnormal_dopamine_level | 1.78776736 |
| 26 | MP0002064_seizures | 1.77544118 |
| 27 | MP0004742_abnormal_vestibular_system | 1.77510516 |
| 28 | MP0001853_heart_inflammation | 1.74902412 |
| 29 | MP0009764_decreased_sensitivity_to | 1.74748897 |
| 30 | MP0005409_darkened_coat_color | 1.71404196 |
| 31 | MP0004947_skin_inflammation | 1.70064639 |
| 32 | MP0002272_abnormal_nervous_system | 1.69711243 |
| 33 | MP0003075_altered_response_to | 1.69710312 |
| 34 | MP0004142_abnormal_muscle_tone | 1.69677559 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.69276671 |
| 36 | MP0001486_abnormal_startle_reflex | 1.69050891 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.68518875 |
| 38 | MP0002229_neurodegeneration | 1.65861157 |
| 39 | MP0002405_respiratory_system_inflammati | 1.65552896 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.63545448 |
| 41 | MP0001851_eye_inflammation | 1.62495313 |
| 42 | MP0008469_abnormal_protein_level | 1.58292682 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.57551010 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.57551010 |
| 45 | MP0008004_abnormal_stomach_pH | 1.55657150 |
| 46 | MP0003631_nervous_system_phenotype | 1.51609592 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.51523735 |
| 48 | MP0003448_altered_tumor_morphology | 1.50094946 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.46915380 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.45746693 |
| 51 | MP0003633_abnormal_nervous_system | 1.44991561 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.44061612 |
| 53 | MP0003136_yellow_coat_color | 1.43886300 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.40415473 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.39791988 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.39009068 |
| 57 | MP0000858_altered_metastatic_potential | 1.38012199 |
| 58 | MP0005410_abnormal_fertilization | 1.37880871 |
| 59 | MP0010678_abnormal_skin_adnexa | 1.35502204 |
| 60 | MP0003436_decreased_susceptibility_to | 1.32172152 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.32158456 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.28498069 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.28373339 |
| 64 | MP0003195_calcinosis | 1.27624237 |
| 65 | MP0004510_myositis | 1.27005603 |
| 66 | MP0001970_abnormal_pain_threshold | 1.25053719 |
| 67 | MP0004381_abnormal_hair_follicle | 1.23934847 |
| 68 | MP0000716_abnormal_immune_system | 1.22712894 |
| 69 | MP0009046_muscle_twitch | 1.19098225 |
| 70 | MP0000747_muscle_weakness | 1.18608095 |
| 71 | MP0002254_reproductive_system_inflammat | 1.16627288 |
| 72 | MP0000383_abnormal_hair_follicle | 1.16415810 |
| 73 | MP0003828_pulmonary_edema | 1.15978016 |
| 74 | MP0005310_abnormal_salivary_gland | 1.12934301 |
| 75 | MP0001790_abnormal_immune_system | 1.11993325 |
| 76 | MP0005387_immune_system_phenotype | 1.11993325 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.11805029 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.10230622 |
| 79 | MP0009745_abnormal_behavioral_response | 1.09868445 |
| 80 | MP0002090_abnormal_vision | 1.09781544 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 1.09653730 |
| 82 | MP0005025_abnormal_response_to | 1.07846716 |
| 83 | MP0000778_abnormal_nervous_system | 1.07668726 |
| 84 | MP0004134_abnormal_chest_morphology | 1.03436979 |
| 85 | MP0002723_abnormal_immune_serum | 1.02425159 |
| 86 | MP0005423_abnormal_somatic_nervous | 1.02414862 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 1.01307434 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 1.01109081 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.99776533 |
| 90 | MP0006054_spinal_hemorrhage | 0.99253134 |
| 91 | MP0005408_hypopigmentation | 0.97163180 |
| 92 | MP0002398_abnormal_bone_marrow | 0.95401930 |
| 93 | MP0002733_abnormal_thermal_nociception | 0.94926532 |
| 94 | MP0005647_abnormal_sex_gland | 0.94048318 |
| 95 | MP0002572_abnormal_emotion/affect_behav | 0.93414839 |
| 96 | MP0002429_abnormal_blood_cell | 0.93271913 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.92495402 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.90390124 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.89925205 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.89147202 |
| 101 | MP0002933_joint_inflammation | 0.89124951 |
| 102 | MP0002736_abnormal_nociception_after | 0.88890820 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.86837377 |
| 104 | MP0005166_decreased_susceptibility_to | 0.85914985 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.85864857 |
| 106 | MP0009763_increased_sensitivity_to | 0.85359983 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.85279822 |
| 108 | MP0000955_abnormal_spinal_cord | 0.84920099 |
| 109 | MP0002882_abnormal_neuron_morphology | 0.84115697 |
| 110 | MP0004883_abnormal_blood_vessel | 0.82651461 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.82646202 |
| 112 | MP0002722_abnormal_immune_system | 0.81777648 |
| 113 | MP0001968_abnormal_touch/_nociception | 0.81677919 |
| 114 | MP0003091_abnormal_cell_migration | 0.80868901 |
| 115 | MP0001440_abnormal_grooming_behavior | 0.79996833 |
| 116 | MP0001800_abnormal_humoral_immune | 0.79803657 |
| 117 | MP0002067_abnormal_sensory_capabilities | 0.79778168 |
| 118 | MP0001958_emphysema | 0.79187053 |
| 119 | MP0005365_abnormal_bile_salt | 0.79050652 |
| 120 | MP0000343_altered_response_to | 0.78969335 |
| 121 | MP0010307_abnormal_tumor_latency | 0.78862431 |
| 122 | MP0008569_lethality_at_weaning | 0.78625061 |
| 123 | MP0005165_increased_susceptibility_to | 0.77957543 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.77860375 |
| 125 | MP0001542_abnormal_bone_strength | 0.77041563 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.76405795 |
| 127 | MP0002420_abnormal_adaptive_immunity | 0.75780076 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.75322415 |
| 129 | MP0001819_abnormal_immune_cell | 0.75171541 |
| 130 | MP0005164_abnormal_response_to | 0.74813235 |
| 131 | MP0008874_decreased_physiological_sensi | 0.74738977 |
| 132 | MP0005390_skeleton_phenotype | 0.73947153 |
| 133 | MP0001963_abnormal_hearing_physiology | 0.72409436 |
| 134 | MP0003795_abnormal_bone_structure | 0.72136085 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.70625804 |
| 136 | MP0000371_diluted_coat_color | 0.70068833 |
| 137 | MP0000015_abnormal_ear_pigmentation | 0.69953087 |
| 138 | MP0004043_abnormal_pH_regulation | 0.69148314 |
| 139 | MP0003724_increased_susceptibility_to | 0.67677732 |
| 140 | MP0003279_aneurysm | 0.67537382 |
| 141 | MP0005671_abnormal_response_to | 0.67354344 |
| 142 | MP0000733_abnormal_muscle_development | 0.67106147 |
| 143 | MP0004185_abnormal_adipocyte_glucose | 0.67063878 |
| 144 | MP0005076_abnormal_cell_differentiation | 0.66481758 |
| 145 | MP0002998_abnormal_bone_remodeling | 0.66311229 |
| 146 | MP0000249_abnormal_blood_vessel | 0.64940777 |
| 147 | MP0009115_abnormal_fat_cell | 0.64268206 |
| 148 | MP0001663_abnormal_digestive_system | 0.61856942 |
| 149 | MP0001849_ear_inflammation | 0.61354066 |
| 150 | MP0000609_abnormal_liver_physiology | 0.59655387 |
| 151 | MP0005319_abnormal_enzyme/_coenzyme | 0.59602751 |
| 152 | MP0003705_abnormal_hypodermis_morpholog | 0.59183392 |
| 153 | MP0009765_abnormal_xenobiotic_induced | 0.58460476 |
| 154 | MP0005257_abnormal_intraocular_pressure | 0.57608154 |
| 155 | MP0003879_abnormal_hair_cell | 0.55104866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.25828184 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.50294051 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.50294051 |
| 4 | Axonal loss (HP:0003447) | 5.45020364 |
| 5 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.19117132 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.76938911 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.54428209 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 4.46169569 |
| 9 | Peripheral hypomyelination (HP:0007182) | 4.35446403 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.34619647 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.31332360 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.18346892 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.18346892 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.18346892 |
| 15 | Onion bulb formation (HP:0003383) | 4.07462177 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 4.04486194 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.81432520 |
| 18 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.67008164 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.65442205 |
| 20 | Parakeratosis (HP:0001036) | 3.59364792 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.45468341 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.43448485 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.39829277 |
| 24 | Insidious onset (HP:0003587) | 3.36384871 |
| 25 | Termporal pattern (HP:0011008) | 3.36384871 |
| 26 | Peripheral demyelination (HP:0011096) | 3.32795013 |
| 27 | Hepatosplenomegaly (HP:0001433) | 3.31119671 |
| 28 | Glomerulonephritis (HP:0000099) | 3.26048958 |
| 29 | Loss of speech (HP:0002371) | 3.25061611 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.20858475 |
| 31 | Slow saccadic eye movements (HP:0000514) | 3.18081942 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.16430776 |
| 33 | Orchitis (HP:0100796) | 3.15381561 |
| 34 | Abnormal auditory evoked potentials (HP:0006958) | 3.11959630 |
| 35 | Agnosia (HP:0010524) | 3.11369946 |
| 36 | Myositis (HP:0100614) | 3.08643442 |
| 37 | Nuclear cataract (HP:0100018) | 3.06653183 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 3.06456975 |
| 39 | Optic neuritis (HP:0100653) | 3.06456975 |
| 40 | Upper motor neuron abnormality (HP:0002127) | 3.05385927 |
| 41 | Neuronal loss in central nervous system (HP:0002529) | 2.96560040 |
| 42 | Clumsiness (HP:0002312) | 2.94605150 |
| 43 | Myocardial infarction (HP:0001658) | 2.77157173 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.76353931 |
| 45 | Ankle clonus (HP:0011448) | 2.74664509 |
| 46 | Spastic tetraparesis (HP:0001285) | 2.72936408 |
| 47 | Progressive neurologic deterioration (HP:0002344) | 2.69581044 |
| 48 | Disinhibition (HP:0000734) | 2.69485833 |
| 49 | Spastic gait (HP:0002064) | 2.66555532 |
| 50 | Intention tremor (HP:0002080) | 2.66400562 |
| 51 | Amyloidosis (HP:0011034) | 2.64287555 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.63836885 |
| 53 | Stomatitis (HP:0010280) | 2.63499183 |
| 54 | J-shaped sella turcica (HP:0002680) | 2.62727915 |
| 55 | Purpura (HP:0000979) | 2.62679162 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.59945436 |
| 57 | Mutism (HP:0002300) | 2.59877712 |
| 58 | Dysmetria (HP:0001310) | 2.59147712 |
| 59 | Hematochezia (HP:0002573) | 2.57997512 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.56246362 |
| 61 | Inappropriate behavior (HP:0000719) | 2.55398908 |
| 62 | Myokymia (HP:0002411) | 2.55170539 |
| 63 | Sensory axonal neuropathy (HP:0003390) | 2.53997335 |
| 64 | Cerebral hypomyelination (HP:0006808) | 2.50207943 |
| 65 | Increased serum ferritin (HP:0003281) | 2.44568448 |
| 66 | Personality changes (HP:0000751) | 2.39506330 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.34416320 |
| 68 | Cerebral hemorrhage (HP:0001342) | 2.33662105 |
| 69 | Thoracic kyphosis (HP:0002942) | 2.30367598 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28822034 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.28822034 |
| 72 | Urinary incontinence (HP:0000020) | 2.27131138 |
| 73 | Recurrent skin infections (HP:0001581) | 2.26285055 |
| 74 | Dementia (HP:0000726) | 2.23170076 |
| 75 | Gingivitis (HP:0000230) | 2.22903295 |
| 76 | Metaphyseal irregularity (HP:0003025) | 2.22164548 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21615205 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21615205 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21615205 |
| 80 | Foot dorsiflexor weakness (HP:0009027) | 2.18655607 |
| 81 | Eczematoid dermatitis (HP:0000976) | 2.17623625 |
| 82 | Hemoptysis (HP:0002105) | 2.16122677 |
| 83 | Global brain atrophy (HP:0002283) | 2.14495732 |
| 84 | Basal ganglia calcification (HP:0002135) | 2.12987464 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.11837415 |
| 86 | Polyneuropathy (HP:0001271) | 2.11754867 |
| 87 | Pathologic fracture (HP:0002756) | 2.11290731 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10881637 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10881637 |
| 90 | Asymmetric septal hypertrophy (HP:0001670) | 2.10553400 |
| 91 | Leukodystrophy (HP:0002415) | 2.08776512 |
| 92 | Cardiomegaly (HP:0001640) | 2.08469765 |
| 93 | Meningitis (HP:0001287) | 2.06569151 |
| 94 | Stridor (HP:0010307) | 2.05937358 |
| 95 | Complement deficiency (HP:0004431) | 2.05394814 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05387758 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 2.04621961 |
| 98 | Akinesia (HP:0002304) | 2.03929923 |
| 99 | Muscle fiber splitting (HP:0003555) | 2.03888170 |
| 100 | Hypoplastic pelvis (HP:0008839) | 2.03328287 |
| 101 | Bone pain (HP:0002653) | 2.00260642 |
| 102 | Apathy (HP:0000741) | 1.98710788 |
| 103 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98149831 |
| 104 | Paraparesis (HP:0002385) | 1.96769331 |
| 105 | Vasculitis (HP:0002633) | 1.96647767 |
| 106 | Scanning speech (HP:0002168) | 1.94995684 |
| 107 | Retinal atrophy (HP:0001105) | 1.94327586 |
| 108 | Recurrent viral infections (HP:0004429) | 1.93820898 |
| 109 | Urticaria (HP:0001025) | 1.93395694 |
| 110 | Petechiae (HP:0000967) | 1.93386318 |
| 111 | Abnormality of the foot musculature (HP:0001436) | 1.92961014 |
| 112 | Thick nail (HP:0001805) | 1.92459147 |
| 113 | Decreased motor nerve conduction velocity (HP:0003431) | 1.91683947 |
| 114 | Obstructive lung disease (HP:0006536) | 1.90717810 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90717810 |
| 116 | Arterial tortuosity (HP:0005116) | 1.88797975 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.88321014 |
| 118 | Progressive visual loss (HP:0000529) | 1.88066660 |
| 119 | Memory impairment (HP:0002354) | 1.87355386 |
| 120 | Increased CSF protein (HP:0002922) | 1.87135526 |
| 121 | Anteriorly placed anus (HP:0001545) | 1.86275117 |
| 122 | Esophageal varix (HP:0002040) | 1.86195474 |
| 123 | Gowers sign (HP:0003391) | 1.83774628 |
| 124 | Metabolic alkalosis (HP:0200114) | 1.82510998 |
| 125 | Keratoconjunctivitis (HP:0001096) | 1.82482264 |
| 126 | Prolonged neonatal jaundice (HP:0006579) | 1.82321777 |
| 127 | Protuberant abdomen (HP:0001538) | 1.82314306 |
| 128 | T lymphocytopenia (HP:0005403) | 1.81751491 |
| 129 | Malnutrition (HP:0004395) | 1.81547472 |
| 130 | Abnormality of complement system (HP:0005339) | 1.80915171 |
| 131 | Abnormality of the periventricular white matter (HP:0002518) | 1.80640730 |
| 132 | Retinal dysplasia (HP:0007973) | 1.80250690 |
| 133 | Increased IgM level (HP:0003496) | 1.79506763 |
| 134 | Prostate neoplasm (HP:0100787) | 1.79199303 |
| 135 | Interstitial pulmonary disease (HP:0006530) | 1.78652349 |
| 136 | Lower limb muscle weakness (HP:0007340) | 1.78246311 |
| 137 | Alacrima (HP:0000522) | 1.77918921 |
| 138 | Action tremor (HP:0002345) | 1.76340242 |
| 139 | Colitis (HP:0002583) | 1.75121367 |
| 140 | Encephalitis (HP:0002383) | 1.74971043 |
| 141 | Morphological abnormality of the inner ear (HP:0011390) | 1.72685999 |
| 142 | Abnormal large intestine physiology (HP:0012700) | 1.72307778 |
| 143 | Spastic paraparesis (HP:0002313) | 1.72047016 |
| 144 | Diminished motivation (HP:0000745) | 1.71896515 |
| 145 | Autoamputation (HP:0001218) | 1.70933027 |
| 146 | Distal sensory impairment (HP:0002936) | 1.69488482 |
| 147 | Nausea (HP:0002018) | 1.68860273 |
| 148 | Hammertoe (HP:0001765) | 1.66714057 |
| 149 | CNS hypomyelination (HP:0003429) | 1.65407830 |
| 150 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.63903580 |
| 151 | Diplopia (HP:0000651) | 1.60935776 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.60935776 |
| 153 | Urinary urgency (HP:0000012) | 1.60930482 |
| 154 | Abnormality of the lumbar spine (HP:0100712) | 1.60568919 |
| 155 | Progressive inability to walk (HP:0002505) | 1.59552685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.03147264 |
| 2 | EPHB1 | 4.20812617 |
| 3 | IRAK3 | 4.08368860 |
| 4 | NME2 | 3.40613107 |
| 5 | MAPKAPK5 | 3.38239216 |
| 6 | OXSR1 | 3.28637748 |
| 7 | TESK2 | 2.86714370 |
| 8 | PKN1 | 2.74002097 |
| 9 | PBK | 2.51179601 |
| 10 | TAOK2 | 2.13644891 |
| 11 | MATK | 2.07045459 |
| 12 | DDR2 | 2.01565253 |
| 13 | MET | 2.00426215 |
| 14 | FGR | 1.87201804 |
| 15 | BLK | 1.85417944 |
| 16 | ERN1 | 1.82582330 |
| 17 | IRAK4 | 1.82450837 |
| 18 | CLK1 | 1.76484280 |
| 19 | MOS | 1.74041539 |
| 20 | MAP2K3 | 1.73008983 |
| 21 | MAP3K13 | 1.72799791 |
| 22 | LIMK1 | 1.71932985 |
| 23 | ARAF | 1.69703637 |
| 24 | MAP3K3 | 1.67557288 |
| 25 | MAP3K11 | 1.66289164 |
| 26 | BCR | 1.60093217 |
| 27 | WNK1 | 1.58712605 |
| 28 | NTRK1 | 1.58624674 |
| 29 | IKBKB | 1.58308543 |
| 30 | WNK4 | 1.54228136 |
| 31 | PRPF4B | 1.52610142 |
| 32 | CDC42BPA | 1.50479793 |
| 33 | JAK3 | 1.47393390 |
| 34 | CSNK1A1L | 1.47337751 |
| 35 | RIPK4 | 1.46118078 |
| 36 | ZAP70 | 1.45897887 |
| 37 | GRK7 | 1.45347604 |
| 38 | TAOK1 | 1.43607487 |
| 39 | UHMK1 | 1.42565825 |
| 40 | CSNK1G3 | 1.41503478 |
| 41 | PIM2 | 1.39946887 |
| 42 | CSF1R | 1.32802640 |
| 43 | IKBKE | 1.30578256 |
| 44 | SGK223 | 1.29275595 |
| 45 | SGK494 | 1.29275595 |
| 46 | MST4 | 1.27164327 |
| 47 | CAMKK2 | 1.27032350 |
| 48 | RIPK1 | 1.25529578 |
| 49 | CAMK1G | 1.15882915 |
| 50 | TESK1 | 1.15078878 |
| 51 | CDK19 | 1.14599397 |
| 52 | CSNK1G2 | 1.14139585 |
| 53 | CAMK2B | 1.13164799 |
| 54 | CASK | 1.13004874 |
| 55 | KIT | 1.11256575 |
| 56 | MAPK15 | 1.11115851 |
| 57 | NEK9 | 1.09622446 |
| 58 | KSR2 | 1.08988374 |
| 59 | SYK | 1.02899876 |
| 60 | FES | 1.02833854 |
| 61 | ACVR1B | 1.02589248 |
| 62 | CSNK1G1 | 1.02420585 |
| 63 | ROCK2 | 1.02302838 |
| 64 | MAP3K9 | 1.00729991 |
| 65 | TRIB3 | 1.00382800 |
| 66 | TAOK3 | 0.98456251 |
| 67 | PNCK | 0.95976111 |
| 68 | CAMK2D | 0.94744359 |
| 69 | TXK | 0.94073766 |
| 70 | CDK6 | 0.93964452 |
| 71 | TRPM7 | 0.91358405 |
| 72 | MAP3K5 | 0.91044743 |
| 73 | CAMK1D | 0.90512305 |
| 74 | NEK6 | 0.90123791 |
| 75 | PDPK1 | 0.86430105 |
| 76 | MUSK | 0.85891734 |
| 77 | IRAK2 | 0.85846187 |
| 78 | DAPK2 | 0.85564713 |
| 79 | MARK2 | 0.84381492 |
| 80 | TYK2 | 0.84086821 |
| 81 | PRKD1 | 0.82655800 |
| 82 | FGFR2 | 0.78310410 |
| 83 | FYN | 0.76128150 |
| 84 | MARK3 | 0.75872530 |
| 85 | CHUK | 0.75411126 |
| 86 | BMPR2 | 0.75311561 |
| 87 | BMPR1B | 0.74979098 |
| 88 | CDK5 | 0.72494178 |
| 89 | BTK | 0.72046121 |
| 90 | HCK | 0.70799612 |
| 91 | CAMK2G | 0.70734316 |
| 92 | TTN | 0.69303149 |
| 93 | LCK | 0.69105983 |
| 94 | TGFBR2 | 0.69008473 |
| 95 | PAK4 | 0.68628929 |
| 96 | PAK6 | 0.67376506 |
| 97 | CAMK2A | 0.66585947 |
| 98 | STK10 | 0.66556157 |
| 99 | ICK | 0.63788148 |
| 100 | PRKCQ | 0.63486099 |
| 101 | DYRK2 | 0.62890525 |
| 102 | DMPK | 0.62116106 |
| 103 | PDK1 | 0.61581792 |
| 104 | MAPK7 | 0.61342364 |
| 105 | TNK2 | 0.60683736 |
| 106 | RPS6KL1 | 0.59658758 |
| 107 | RPS6KC1 | 0.59658758 |
| 108 | ERBB4 | 0.59646975 |
| 109 | GSK3A | 0.57940836 |
| 110 | TBK1 | 0.57096282 |
| 111 | PRKCE | 0.56637489 |
| 112 | RPS6KA2 | 0.55823382 |
| 113 | MAP2K2 | 0.54891698 |
| 114 | TYRO3 | 0.54311994 |
| 115 | CDK14 | 0.54112716 |
| 116 | CSK | 0.53965730 |
| 117 | DAPK3 | 0.53187023 |
| 118 | RPS6KA5 | 0.52992224 |
| 119 | SCYL2 | 0.52580827 |
| 120 | SIK3 | 0.51786302 |
| 121 | ITK | 0.51152924 |
| 122 | PRKCH | 0.49968650 |
| 123 | GRK5 | 0.49112556 |
| 124 | CDK15 | 0.48536266 |
| 125 | CAMKK1 | 0.48121551 |
| 126 | PRKG1 | 0.47181193 |
| 127 | MAP2K6 | 0.47018656 |
| 128 | BMX | 0.46894023 |
| 129 | RPS6KA6 | 0.45343681 |
| 130 | MAP3K14 | 0.45091549 |
| 131 | MAP3K8 | 0.44929256 |
| 132 | JAK1 | 0.44198890 |
| 133 | MAPK12 | 0.44183892 |
| 134 | MAP3K6 | 0.44134479 |
| 135 | PIM1 | 0.43925842 |
| 136 | ABL2 | 0.43700458 |
| 137 | MAP4K1 | 0.42983954 |
| 138 | CDK18 | 0.41990760 |
| 139 | PHKG1 | 0.41767334 |
| 140 | PHKG2 | 0.41767334 |
| 141 | ABL1 | 0.40626094 |
| 142 | LYN | 0.40056837 |
| 143 | PDK2 | 0.40036571 |
| 144 | EGFR | 0.39812510 |
| 145 | PRKD3 | 0.39528521 |
| 146 | MAP3K1 | 0.39378255 |
| 147 | ADRBK2 | 0.39041990 |
| 148 | JAK2 | 0.38266724 |
| 149 | MAPK4 | 0.37440454 |
| 150 | IRAK1 | 0.36494811 |
| 151 | PDGFRA | 0.34472465 |
| 152 | SGK3 | 0.32816414 |
| 153 | PRKG2 | 0.30547339 |
| 154 | MAPKAPK2 | 0.29578229 |
| 155 | KSR1 | 0.29026185 |
| 156 | SMG1 | 0.28924689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.20378620 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.08533175 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.12747157 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.81330523 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.80541990 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.68146273 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.44000826 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.32203453 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.30640924 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.29900644 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01394060 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00381701 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98096723 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92886804 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.91577915 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.90820536 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86333642 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83921405 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82749513 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80269857 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.79827683 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.79784981 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70781362 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60224283 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59849390 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58510176 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57501173 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56131827 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.47910462 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.43676239 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.40420862 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.36810303 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36756804 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35332517 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34716168 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29790861 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29207109 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29082265 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26978412 |
| 40 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.24016329 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.22614743 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14676365 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10947762 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 1.08653645 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08349886 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07130501 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06441249 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.06375378 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04378207 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03920524 |
| 51 | Measles_Homo sapiens_hsa05162 | 1.02434741 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00250407 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98815454 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97353782 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96917117 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93370945 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92473500 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.92468199 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92430107 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92407937 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91794727 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.91534294 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.90453232 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89697847 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.87976777 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87338010 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.86872860 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.85929971 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85863153 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85226613 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84988157 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84451248 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.83559266 |
| 74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83419515 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82043459 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81929804 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81433999 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.80373229 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.79245233 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77483740 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75975057 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.75182472 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74902230 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.74573236 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73907665 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71730211 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70498172 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69638654 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64901757 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64531631 |
| 91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.64000626 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63514455 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63186101 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63072529 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62789306 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.60486588 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60426649 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60366450 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59849344 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57096881 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55642371 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55260320 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51930871 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51854368 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51719431 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51473303 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50339928 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.49606823 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49096785 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48995802 |
| 111 | Salivary secretion_Homo sapiens_hsa04970 | 0.48542954 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48379265 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.47997959 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47325712 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46391293 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43697258 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.42668129 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41204362 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40974859 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40190417 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40141780 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40065657 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39961809 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39335460 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38762494 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37828581 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36082401 |
| 128 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35899046 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35470308 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35232298 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34798392 |
| 132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34550408 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33989656 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33958798 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33369298 |
| 136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32426547 |
| 137 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31945138 |
| 138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31835078 |
| 139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31685887 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.30916612 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30666203 |
| 142 | ABC transporters_Homo sapiens_hsa02010 | 0.30226981 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.30142608 |
| 144 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29985018 |
| 145 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26080127 |
| 146 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25601615 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22996303 |
| 148 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21932821 |
| 149 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21203324 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.20769626 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19503582 |
| 152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19114911 |

